The evidence a credible program relies on Legitimate prescribing sits on an established evidence base: STEP for semaglutide in weight management ( The New England Journal of Medicine , 2021), SURMOUNT for tirzepatide in weight management (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024)
Limited Long-term Data : While short- to medium-term data are compelling, the long-term safety and efficacy profile over decades of treatment remains incompletely characterized
Regular blood tests ordered by a healthcare provider will also track long-term blood sugar control through hemoglobin A1c levels
validated by IP Fluorogold injection in WD mice in Supplementary Fig
For comprehensive strategies on preventing weight regain after stopping treatment, see our complete retatrutide maintenance and weight regain guide
Interindividual differences contribute to variation in microbiota composition more than hormonal status: A prospective study